Cardiac Disease Evaluation For Kidney And Liver Transplant Candidates

Animal Models of Heart Failure Banner

Cardiac Disease Evaluation and Management Among Kidney and Liver Transplantation Candidates

Circ Journal Cover for Science News     
  • Cardiovascular disease is a major cause of morbidity and mortality for those with end-stage non-cardiac organ failure both before and after transplantation.
  • The unique characteristics of end-organ failure transplant candidates require careful consideration during cardiac evaluation.
  • This paper addresses gaps in existing guidelines for consideration during cardiac disease evaluation in kidney and liver transplant candidates.
    Read the full article in Circulation
    Circulation. 2012: published online before print July 2, 2012, 10.1161/CIR.0b013e31823eb07a.

Supporting Materials
  • Commentary:  Bringing Harmony to the Cacophony of Cardiovascular Disease Assessment for Potential Kidney Liver Transplant Candidates. A Case for Assimilating the New AHA/ACCF Guidelines by Christopher deFilippi, MD
  • Top 10 Things To Know
Other Resources
Related Statements and Guidelines
Posted by Stacy AHA Science on Jul 2, 2012 5:06 PM America/Chicago